Cargando…
Preclinical Head and Neck Squamous Cell Carcinoma Models for Combined Targeted Therapy Approaches
SIMPLE SUMMARY: Head and neck squamous cell carcinoma are characterized by a high degree of inter- and intratumoral heterogeneity. Well-characterized preclinical models represent the heterogeneity of this disease and enable the development of innovative therapeutic concepts. The present work dealt w...
Autores principales: | Schoenwaelder, Nina, Krause, Mareike, Freitag, Thomas, Schneider, Björn, Zonnur, Sarah, Zimpfer, Annette, Becker, Anne Sophie, Salewski, Inken, Strüder, Daniel Fabian, Lemcke, Heiko, Grosse-Thie, Christina, Junghanss, Christian, Maletzki, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139292/ https://www.ncbi.nlm.nih.gov/pubmed/35626088 http://dx.doi.org/10.3390/cancers14102484 |
Ejemplares similares
-
The Individual Effects of Cyclin-Dependent Kinase Inhibitors on Head and Neck Cancer Cells—A Systematic Analysis
por: Schoenwaelder, Nina, et al.
Publicado: (2021) -
Establishment and characterization of patient-derived head and neck cancer models from surgical specimens and endoscopic biopsies
por: Strüder, Daniel, et al.
Publicado: (2021) -
Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?
por: Riess, Christin, et al.
Publicado: (2020) -
Combined Gemcitabine and Immune-Checkpoint Inhibition Conquers Anti-PD-L1 Resistance in Low-Immunogenic Mismatch Repair-Deficient Tumors
por: Salewski, Inken, et al.
Publicado: (2021) -
CDK4/6 blockade provides an alternative approach for treatment of mismatch-repair deficient tumors
por: Salewski, Inken, et al.
Publicado: (2022)